Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model. (49/86)

 (+info)

Runx1/Cbfbeta2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages. (50/86)

 (+info)

CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells. (51/86)

 (+info)

Core binding factor beta functions in the maintenance of stem cells and orchestrates continuous proliferation and differentiation in mouse incisors. (52/86)

 (+info)

miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies. (53/86)

 (+info)

The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. (54/86)

 (+info)

Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbeta-dependent expression of the Wnt antagonist, sclerostin. (55/86)

 (+info)

Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. (56/86)

 (+info)